Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Resistin -420C>G promoter variant and colorectal cancer risk.

Mahmoudi T, Karimi K, Arkani M, Farahani H, Vahedi M, Dabiri R, Nobakht H, Asadi A, Mirakhorli M, Arshi B, Derakhshan A, Zali MR.

Int J Biol Markers. 2014 Sep 30;29(3):e233-8. doi: 10.5301/jbm.5000079.

PMID:
24585435
2.

Gly972Arg variant of insulin receptor substrate 1 gene and colorectal cancer risk in overweight/obese subjects.

Mahmoudi T, Majidzadeh-A K, Karimi K, Farahani H, Dabiri R, Nobakht H, Asadi A, Karimi N, Arkani M, Zali MR.

Int J Biol Markers. 2016 Feb 28;31(1):e68-72. doi: 10.5301/jbm.5000159.

PMID:
26349669
3.

A polymorphism in the resistin gene promoter and the risk of coronary artery disease in a Chinese population.

Tang NP, Wang LS, Yang L, Zhou B, Gu HJ, Sun QM, Cong RH, Zhu HJ, Wang B.

Clin Endocrinol (Oxf). 2008 Jan;68(1):82-7. Epub 2007 Aug 28.

PMID:
17727677
4.

Association of -394C>G and -420C>G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese.

Chi S, Lan C, Zhang S, Liu H, Wang X, Chen Y, Chen X, Chen S, Zhang W.

Mol Cell Biochem. 2009 Oct;330(1-2):31-8. doi: 10.1007/s11010-009-0097-2. Epub 2009 Apr 21.

PMID:
19381781
5.

Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.

Norata GD, Ongari M, Garlaschelli K, Tibolla G, Grigore L, Raselli S, Vettoretti S, Baragetti I, Noto D, Cefalù AB, Buccianti G, Averna M, Catapano AL.

J Intern Med. 2007 Jul;262(1):104-12.

6.

Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype.

Wågsater D, Mumtaz M, Lofgren S, Hugander A, Dimberg J.

Cancer Invest. 2008 Dec;26(10):1008-14. doi: 10.1080/07357900802087267.

PMID:
18798067
7.

Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study.

Hivert MF, Manning AK, McAteer JB, Dupuis J, Fox CS, Cupples LA, Meigs JB, Florez JC.

Diabetes. 2009 Mar;58(3):750-6. doi: 10.2337/db08-1339. Epub 2008 Dec 15.

8.

Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population.

Zhang X, Zhai L, Rong C, Qin X, Li S.

PLoS One. 2015 Nov 23;10(11):e0143069. doi: 10.1371/journal.pone.0143069. eCollection 2015.

9.

Genetic variation in adipokine genes and risk of colorectal cancer.

Pechlivanis S, Bermejo JL, Pardini B, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Försti A.

Eur J Endocrinol. 2009 Jun;160(6):933-40. doi: 10.1530/EJE-09-0039. Epub 2009 Mar 9. Erratum in: Eur J Endocrinol. 2009 Jul;161(1):211.

10.

Associations of Resistin Levels with Resistin Gene Polymorphism and Metabolic Syndrome in Thais.

Suriyaprom K, Tungtrongchitr R, Namjuntra P.

J Med Biochem. 2015 Apr;34(2):170-178. doi: 10.2478/jomb-2014-0034. Epub 2015 Mar 3.

11.

Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients.

El-Shal AS, Pasha HF, Rashad NM.

Gene. 2013 Feb 15;515(1):233-8. doi: 10.1016/j.gene.2012.09.136. Epub 2012 Nov 20.

PMID:
23178185
12.

Resistin gene polymorphisms are associated with acne and serum lipid levels, providing a potential nexus between lipid metabolism and inflammation.

Younis S, Blumenberg M, Javed Q.

Arch Dermatol Res. 2016 May;308(4):229-37. doi: 10.1007/s00403-016-1626-y. Epub 2016 Feb 8.

PMID:
26858108
13.

An exon variant in insulin receptor gene is associated with susceptibility to colorectal cancer in women.

Mahmoudi T, Majidzadeh-A K, Karimi K, Karimi N, Farahani H, Dabiri R, Nobakht H, Dolatmoradi H, Arkani M, Zali MR.

Tumour Biol. 2015 May;36(5):3709-15. doi: 10.1007/s13277-014-3010-x. Epub 2015 Jan 5.

PMID:
25557790
14.
15.

Possible relationship between the resistin gene C-420G polymorphism and colorectal cancer in a Turkish population.

Düzköylü Y, Arıkan S, Turan S, Yaylım İ, Doğan MB, Sarı S, Ersöz F, Zeybek Ü, Tımırcı Kahraman Ö, Çelikel B, Erdem S.

Turk J Gastroenterol. 2015 Sep;26(5):392-6. doi: 10.5152/tjg.2015.0188. Epub 2015 Jul 24.

16.

Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients.

Alharithy RN.

Ann Saudi Med. 2014 Jul-Aug;34(4):334-9. doi: 10.5144/0256-4947.2014.334.

17.

APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.

Zhang SH, Wang LA, Li Z, Peng Y, Cun YP, Dai N, Cheng Y, Xiao H, Xiong YL, Wang D.

World J Gastroenterol. 2014 Jul 14;20(26):8700-8. doi: 10.3748/wjg.v20.i26.8700.

18.

[Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].

Bao Q, He BS, Chen LP, Gu L, Nie ZL, Wang SK.

Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jan;46(1):53-7. Chinese.

PMID:
22490141
19.

Significant interaction between RETN -420 G/G genotype and lower BMI on decreased risk of type 2 diabetes mellitus (T2DM) in Japanese--the J-MICC Study.

Hishida A, Wakai K, Okada R, Morita E, Hamajima N, Hosono S, Higaki Y, Turin TC, Suzuki S, Motahareh K, Mikami H, Tashiro N, Watanabe I, Katsuura S, Kubo M, Tanaka H, Naito M.

Endocr J. 2013;60(2):237-43. Epub 2013 Jan 18.

20.

Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.

Oh J, Kim JW, Lee BE, Jang MJ, Chong SY, Park PW, Hwang SG, Oh D, Kim NK.

Oncol Rep. 2014 Feb;31(2):995-1002. doi: 10.3892/or.2013.2926. Epub 2013 Dec 13.

PMID:
24337371

Supplemental Content

Support Center